These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 18316577

  • 1. Synergy of a herpes oncolytic virus and paclitaxel for anaplastic thyroid cancer.
    Lin SF, Gao SP, Price DL, Li S, Chou TC, Singh P, Huang YY, Fong Y, Wong RJ.
    Clin Cancer Res; 2008 Mar 01; 14(5):1519-28. PubMed ID: 18316577
    [Abstract] [Full Text] [Related]

  • 2. An oncolytic herpes simplex virus vector, G47Δ, synergizes with paclitaxel in the treatment of breast cancer.
    Zeng WG, Li JJ, Hu P, Lei L, Wang JN, Liu RB.
    Oncol Rep; 2013 Jun 01; 29(6):2355-61. PubMed ID: 23525624
    [Abstract] [Full Text] [Related]

  • 3. Treatment of cholangiocarcinoma with oncolytic herpes simplex virus combined with external beam radiation therapy.
    Jarnagin WR, Zager JS, Hezel M, Stanziale SF, Adusumilli PS, Gonen M, Ebright MI, Culliford A, Gusani NJ, Fong Y.
    Cancer Gene Ther; 2006 Mar 01; 13(3):326-34. PubMed ID: 16138120
    [Abstract] [Full Text] [Related]

  • 4. Effect of chemotherapy-induced DNA repair on oncolytic herpes simplex viral replication.
    Aghi M, Rabkin S, Martuza RL.
    J Natl Cancer Inst; 2006 Jan 04; 98(1):38-50. PubMed ID: 16391370
    [Abstract] [Full Text] [Related]

  • 5. ONYX-411, a conditionally replicative oncolytic adenovirus, induces cell death in anaplastic thyroid carcinoma cell lines and suppresses the growth of xenograft tumors in nude mice.
    Reddi HV, Madde P, Reichert-Eberhardt AJ, Galanis EC, Copland JA, McIver B, Grebe SK, Eberhardt NL.
    Cancer Gene Ther; 2008 Nov 04; 15(11):750-7. PubMed ID: 18583996
    [Abstract] [Full Text] [Related]

  • 6. Lovastatin enhances the replication of the oncolytic adenovirus dl1520 and its antineoplastic activity against anaplastic thyroid carcinoma cells.
    Libertini S, Iacuzzo I, Ferraro A, Vitale M, Bifulco M, Fusco A, Portella G.
    Endocrinology; 2007 Nov 04; 148(11):5186-94. PubMed ID: 17690162
    [Abstract] [Full Text] [Related]

  • 7. Potent oncolytic activity of multimutated herpes simplex virus G207 in combination with vincristine against human rhabdomyosarcoma.
    Cinatl J, Cinatl J, Michaelis M, Kabickova H, Kotchetkov R, Vogel JU, Doerr HW, Klingebiel T, Driever PH.
    Cancer Res; 2003 Apr 01; 63(7):1508-14. PubMed ID: 12670897
    [Abstract] [Full Text] [Related]

  • 8. Enhanced cytotoxicity with a novel system combining the paclitaxel-2'-ethylcarbonate prodrug and an HSV amplicon with an attenuated replication-competent virus, HF10 as a helper virus.
    Ishida D, Nawa A, Tanino T, Goshima F, Luo CH, Iwaki M, Kajiyama H, Shibata K, Yamamoto E, Ino K, Tsurumi T, Nishiyama Y, Kikkawa F.
    Cancer Lett; 2010 Feb 01; 288(1):17-27. PubMed ID: 19604626
    [Abstract] [Full Text] [Related]

  • 9. Hypoxia enhances the replication of oncolytic herpes simplex virus.
    Aghi MK, Liu TC, Rabkin S, Martuza RL.
    Mol Ther; 2009 Jan 01; 17(1):51-6. PubMed ID: 18957963
    [Abstract] [Full Text] [Related]

  • 10. Enhanced therapeutic efficacy of oncolytic herpes vector G207 against human non-small cell lung cancer--expression of an RNA-binding protein, Musashi1, as a marker for the tailored gene therapy.
    Kanai R, Eguchi K, Takahashi M, Goldman S, Okano H, Kawase T, Yazaki T.
    J Gene Med; 2006 Nov 01; 8(11):1329-40. PubMed ID: 16955534
    [Abstract] [Full Text] [Related]

  • 11. Treatment of aggressive thyroid cancer with an oncolytic herpes virus.
    Yu Z, Eisenberg DP, Singh B, Shah JP, Fong Y, Wong RJ.
    Int J Cancer; 2004 Nov 10; 112(3):525-32. PubMed ID: 15382081
    [Abstract] [Full Text] [Related]

  • 12. Doxorubicin synergizes with 34.5ENVE to enhance antitumor efficacy against metastatic ovarian cancer.
    Bolyard C, Yoo JY, Wang PY, Saini U, Rath KS, Cripe TP, Zhang J, Selvendiran K, Kaur B.
    Clin Cancer Res; 2014 Dec 15; 20(24):6479-94. PubMed ID: 25294909
    [Abstract] [Full Text] [Related]

  • 13. The control of anaplastic thyroid carcinoma cell lines by oncolytic poxviruses.
    Mundi N, Um S, Yoo J, Rizzo G, Black M, Pinto N, Palma DA, Fung K, MacNeil D, Mymryk JS, Barrett JW, Nichols AC.
    Virus Res; 2014 Sep 22; 190():53-9. PubMed ID: 25038405
    [Abstract] [Full Text] [Related]

  • 14. Replication-competent herpes simplex virus vector G207 and cisplatin combination therapy for head and neck squamous cell carcinoma.
    Chahlavi A, Todo T, Martuza RL, Rabkin SD.
    Neoplasia; 1999 Jun 22; 1(2):162-9. PubMed ID: 10933051
    [Abstract] [Full Text] [Related]

  • 15. An armed oncolytic herpes simplex virus expressing thrombospondin-1 has an enhanced in vivo antitumor effect against human gastric cancer.
    Tsuji T, Nakamori M, Iwahashi M, Nakamura M, Ojima T, Iida T, Katsuda M, Hayata K, Ino Y, Todo T, Yamaue H.
    Int J Cancer; 2013 Jan 15; 132(2):485-94. PubMed ID: 22729516
    [Abstract] [Full Text] [Related]

  • 16. Combination of mutated herpes simplex virus type 1 (G207 virus) with radiation for the treatment of squamous cell carcinoma of the head and neck.
    Kim SH, Wong RJ, Kooby DA, Carew JF, Adusumilli PS, Patel SG, Shah JP, Fong Y.
    Eur J Cancer; 2005 Jan 15; 41(2):313-22. PubMed ID: 15661558
    [Abstract] [Full Text] [Related]

  • 17. Enhanced antitumor efficacy of low-dose Etoposide with oncolytic herpes simplex virus in human glioblastoma stem cell xenografts.
    Cheema TA, Kanai R, Kim GW, Wakimoto H, Passer B, Rabkin SD, Martuza RL.
    Clin Cancer Res; 2011 Dec 01; 17(23):7383-93. PubMed ID: 21976549
    [Abstract] [Full Text] [Related]

  • 18. Corticosteroid administration does not affect viral oncolytic activity, but inhibits antitumor immunity in replication-competent herpes simplex virus tumor therapy.
    Todo T, Rabkin SD, Chahlavi A, Martuza RL.
    Hum Gene Ther; 1999 Nov 20; 10(17):2869-78. PubMed ID: 10584932
    [Abstract] [Full Text] [Related]

  • 19. Enhanced efficacy of conditionally replicating herpes simplex virus (G207) combined with 5-fluorouracil and surgical resection in peritoneal cancer dissemination models.
    Nakano K, Todo T, Zhao G, Yamaguchi K, Kuroki S, Cohen JB, Glorioso JC, Tanaka M.
    J Gene Med; 2005 May 20; 7(5):638-48. PubMed ID: 15754306
    [Abstract] [Full Text] [Related]

  • 20. Preclinical efficacy of the oncolytic measles virus expressing the sodium iodide symporter in iodine non-avid anaplastic thyroid cancer: a novel therapeutic agent allowing noninvasive imaging and radioiodine therapy.
    Reddi HV, Madde P, McDonough SJ, Trujillo MA, Morris JC, Myers RM, Peng KW, Russell SJ, McIver B, Eberhardt NL.
    Cancer Gene Ther; 2012 Sep 20; 19(9):659-65. PubMed ID: 22790962
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.